Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000599457 | SCV000709963 | pathogenic | not provided | 2020-01-18 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 16392638, 29800625, 29709427, 12673275, 25764262, 16604369, 16127278, 24969777, 23485117, 18157818, 15727254, 20189652, 16835894, 32818659) |
Labcorp Genetics |
RCV000599457 | SCV002205142 | pathogenic | not provided | 2025-01-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Lys1394Asnfs*9) in the ABCC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCC6 are known to be pathogenic (PMID: 11536079, 17617515). This variant is present in population databases (rs67791546, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with pseudoxanthoma elasticum (PMID: 12673275). ClinVar contains an entry for this variant (Variation ID: 433351). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV002489228 | SCV002782331 | pathogenic | Autosomal recessive inherited pseudoxanthoma elasticum; Pseudoxanthoma elasticum, forme fruste; Arterial calcification, generalized, of infancy, 2 | 2021-09-05 | criteria provided, single submitter | clinical testing | |
PXE International | RCV000499133 | SCV000589110 | pathogenic | Autosomal recessive inherited pseudoxanthoma elasticum | 2021-03-01 | no assertion criteria provided | research | |
Genome |
RCV000499133 | SCV002074858 | not provided | Autosomal recessive inherited pseudoxanthoma elasticum | no assertion provided | phenotyping only | Variant interpreted as Pathogenic and reported on 11-18-2019 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |